Fortrea (FTRE) Competitors

$14.47 -0.14 (-0.96%)

Closing price 05/13/2026 04:00 PM Eastern

Extended Trading

$14.48 +0.01 (+0.07%)

As of 05/13/2026 04:12 PM Eastern

FTRE vs. RDNT, SHC, BLLN, OPCH, and PRVA

Should you buy Fortrea stock or one of its competitors? MarketBeat compares Fortrea with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fortrea include RadNet (RDNT), Sotera Health (SHC), Billiontoone (BLLN), Option Care Health (OPCH), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry.

How does Fortrea compare to RadNet?

RadNet (NASDAQ:RDNT) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

RadNet has higher earnings, but lower revenue than Fortrea. RadNet is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.04	-$18.65M	-$0.18	N/A
Fortrea	$2.72B	0.50	-$986.20M	-$4.91	N/A

RadNet has a net margin of -0.66% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Fortrea	-16.50%	9.51%	1.96%

RadNet has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market. Comparatively, Fortrea has a beta of 1.92, indicating that its share price is 92% more volatile than the broader market.

In the previous week, RadNet had 7 more articles in the media than Fortrea. MarketBeat recorded 12 mentions for RadNet and 5 mentions for Fortrea. Fortrea's average media sentiment score of 0.55 beat RadNet's score of 0.45 indicating that Fortrea is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fortrea	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet currently has a consensus target price of $88.14, suggesting a potential upside of 66.37%. Fortrea has a consensus target price of $17.25, suggesting a potential upside of 19.21%. Given RadNet's stronger consensus rating and higher probable upside, equities analysts plainly believe RadNet is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36

77.9% of RadNet shares are held by institutional investors. 5.6% of RadNet shares are held by insiders. Comparatively, 0.4% of Fortrea shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

RadNet beats Fortrea on 11 of the 17 factors compared between the two stocks.

How does Fortrea compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability.

Sotera Health currently has a consensus price target of $20.33, suggesting a potential upside of 31.35%. Fortrea has a consensus price target of $17.25, suggesting a potential upside of 19.21%. Given Sotera Health's stronger consensus rating and higher possible upside, research analysts plainly believe Sotera Health is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36

Sotera Health has a beta of 1.82, indicating that its stock price is 82% more volatile than the broader market. Comparatively, Fortrea has a beta of 1.92, indicating that its stock price is 92% more volatile than the broader market.

91.0% of Sotera Health shares are held by institutional investors. 15.4% of Sotera Health shares are held by company insiders. Comparatively, 0.4% of Fortrea shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sotera Health has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	3.79	$77.94M	$0.41	37.76
Fortrea	$2.72B	0.50	-$986.20M	-$4.91	N/A

Sotera Health has a net margin of 9.91% compared to Fortrea's net margin of -16.50%. Sotera Health's return on equity of 39.73% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Fortrea	-16.50%	9.51%	1.96%

In the previous week, Sotera Health had 5 more articles in the media than Fortrea. MarketBeat recorded 10 mentions for Sotera Health and 5 mentions for Fortrea. Sotera Health's average media sentiment score of 0.56 beat Fortrea's score of 0.55 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	4 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fortrea	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Sotera Health beats Fortrea on 14 of the 16 factors compared between the two stocks.

How does Fortrea compare to Billiontoone?

Fortrea (NASDAQ:FTRE) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

Fortrea presently has a consensus price target of $17.25, suggesting a potential upside of 19.21%. Billiontoone has a consensus price target of $125.29, suggesting a potential upside of 38.30%. Given Billiontoone's stronger consensus rating and higher possible upside, analysts clearly believe Billiontoone is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Billiontoone has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.50	-$986.20M	-$4.91	N/A
Billiontoone	$354.54M	11.75	$7.45M	$0.55	164.71

Billiontoone has a net margin of 0.00% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Billiontoone	N/A	N/A	N/A

In the previous week, Billiontoone had 5 more articles in the media than Fortrea. MarketBeat recorded 10 mentions for Billiontoone and 5 mentions for Fortrea. Fortrea's average media sentiment score of 0.55 beat Billiontoone's score of 0.55 indicating that Fortrea is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Billiontoone beats Fortrea on 9 of the 13 factors compared between the two stocks.

How does Fortrea compare to Option Care Health?

Option Care Health (NASDAQ:OPCH) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

Option Care Health presently has a consensus price target of $31.25, suggesting a potential upside of 57.99%. Fortrea has a consensus price target of $17.25, suggesting a potential upside of 19.21%. Given Option Care Health's stronger consensus rating and higher possible upside, research analysts clearly believe Option Care Health is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Option Care Health	1 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.69
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36

In the previous week, Option Care Health had 15 more articles in the media than Fortrea. MarketBeat recorded 20 mentions for Option Care Health and 5 mentions for Fortrea. Option Care Health's average media sentiment score of 0.77 beat Fortrea's score of 0.55 indicating that Option Care Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Option Care Health	11 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Fortrea	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Option Care Health has a net margin of 3.64% compared to Fortrea's net margin of -16.50%. Option Care Health's return on equity of 18.17% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Option Care Health	3.64%	18.17%	7.16%
Fortrea	-16.50%	9.51%	1.96%

Option Care Health has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, Fortrea has a beta of 1.92, suggesting that its stock price is 92% more volatile than the broader market.

Option Care Health has higher revenue and earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Option Care Health	$5.65B	0.55	$207.59M	$1.29	15.33
Fortrea	$2.72B	0.50	-$986.20M	-$4.91	N/A

98.1% of Option Care Health shares are owned by institutional investors. 1.7% of Option Care Health shares are owned by insiders. Comparatively, 0.4% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Option Care Health beats Fortrea on 16 of the 17 factors compared between the two stocks.

How does Fortrea compare to Privia Health Group?

Fortrea (NASDAQ:FTRE) and Privia Health Group (NASDAQ:PRVA) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

Fortrea has a beta of 1.92, indicating that its stock price is 92% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.96, indicating that its stock price is 4% less volatile than the broader market.

94.5% of Privia Health Group shares are owned by institutional investors. 0.4% of Fortrea shares are owned by company insiders. Comparatively, 5.7% of Privia Health Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Privia Health Group had 17 more articles in the media than Fortrea. MarketBeat recorded 22 mentions for Privia Health Group and 5 mentions for Fortrea. Fortrea's average media sentiment score of 0.55 beat Privia Health Group's score of 0.54 indicating that Fortrea is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Privia Health Group	7 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Privia Health Group has a net margin of 0.97% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Privia Health Group	0.97%	2.81%	1.61%

Fortrea currently has a consensus price target of $17.25, indicating a potential upside of 19.21%. Privia Health Group has a consensus price target of $31.23, indicating a potential upside of 38.01%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts clearly believe Privia Health Group is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Privia Health Group has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.50	-$986.20M	-$4.91	N/A
Privia Health Group	$2.12B	1.34	$22.92M	$0.16	141.44

Summary

Privia Health Group beats Fortrea on 11 of the 16 factors compared between the two stocks.

Get Fortrea News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FTRE vs. The Competition

Export

Metric	Fortrea	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.38B	$3.42B	$6.30B	$12.20B
Dividend Yield	N/A	2.30%	2.79%	5.30%
P/E Ratio	-2.95	18.52	21.00	25.58
Price / Sales	0.50	301.14	554.55	78.84
Price / Cash	1.47	122.51	42.94	55.34
Price / Book	2.60	6.75	9.75	6.66
Net Income	-$986.20M	$24.11M	$3.55B	$333.63M
7 Day Performance	-7.06%	-0.53%	-0.53%	-0.11%
1 Month Performance	50.89%	0.34%	1.20%	3.94%
1 Year Performance	202.72%	78.62%	41.22%	36.07%

Fortrea Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FTRE Fortrea	3.2891 of 5 stars	$14.47 -1.0%	$17.25 +19.2%	+189.4%	$1.38B	$2.72B	N/A	14,300	Analyst Forecast Gap Up
RDNT RadNet	3.2413 of 5 stars	$58.26 +2.5%	$88.14 +51.3%	-12.5%	$4.45B	$2.04B	N/A	11,264	Earnings Report Analyst Downgrade
SHC Sotera Health	3.7271 of 5 stars	$15.39 -0.7%	$20.67 +34.3%	+16.9%	$4.42B	$1.16B	57.00	3,000
BLLN Billiontoone	4.0232 of 5 stars	$72.12 -6.9%	$126.71 +75.7%	N/A	$3.56B	$305.11M	343.43	620	Analyst Forecast
OPCH Option Care Health	4.9353 of 5 stars	$21.14 +5.5%	$32.08 +51.8%	-37.3%	$3.14B	$5.65B	16.39	8,266	Analyst Downgrade High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FTRE) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fortrea (FTRE) Competitors

FTRE vs. RDNT, SHC, BLLN, OPCH, and PRVA

How does Fortrea compare to RadNet?

Summary

How does Fortrea compare to Sotera Health?

Summary

How does Fortrea compare to Billiontoone?

Summary

How does Fortrea compare to Option Care Health?

Summary

How does Fortrea compare to Privia Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE vs. The Competition

Fortrea Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fortrea (FTRE) Competitors

FTRE vs. RDNT, SHC, BLLN, OPCH, and PRVA

How does Fortrea compare to RadNet?

Which has stronger earnings & valuation, RDNT or FTRE?

Is RDNT or FTRE more profitable?

Which has more risk and volatility, RDNT or FTRE?

Does the media favor RDNT or FTRE?

Do analysts prefer RDNT or FTRE?

Do institutionals and insiders hold more shares of RDNT or FTRE?

Summary

How does Fortrea compare to Sotera Health?

Do analysts prefer SHC or FTRE?

Which has more risk & volatility, SHC or FTRE?

Do insiders & institutionals hold more shares of SHC or FTRE?

Which has higher earnings and valuation, SHC or FTRE?

Is SHC or FTRE more profitable?

Does the media refer more to SHC or FTRE?

Summary

How does Fortrea compare to Billiontoone?

Do analysts prefer FTRE or BLLN?

Which has stronger valuation & earnings, FTRE or BLLN?

Is FTRE or BLLN more profitable?

Does the media refer more to FTRE or BLLN?

Summary

How does Fortrea compare to Option Care Health?

Do analysts rate OPCH or FTRE?

Does the media prefer OPCH or FTRE?

Is OPCH or FTRE more profitable?

Which has more volatility & risk, OPCH or FTRE?

Which has better valuation & earnings, OPCH or FTRE?

Do institutionals and insiders hold more shares of OPCH or FTRE?

Summary

How does Fortrea compare to Privia Health Group?

Which has more risk & volatility, FTRE or PRVA?

Do institutionals and insiders have more ownership in FTRE or PRVA?

Does the media refer more to FTRE or PRVA?

Is FTRE or PRVA more profitable?

Do analysts rate FTRE or PRVA?

Which has better valuation and earnings, FTRE or PRVA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE vs. The Competition

Fortrea Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools